Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Shares of NTRA Down 31.7% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Natera Inc (NASDAQ:NTRA) on September 13th, 2018 at $24.86. In approximately 3 months, Natera Inc has returned 31.74% as of today's recent price of $16.97.

NTRA : 17.00 (-0.70%)
Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of cell-free DNA, presented data from two studies this week at the 2018 San Antonio Breast Cancer Symposium (SABCS),...

NTRA : 17.00 (-0.70%)
Natera Achieves Enrollment Goal of 20,000 Patients in SMART Study

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has enrolled 20,000 patients in the SMART (SNP-based Microdeletion and Aneuploidy Registry Trial) study, designed...

NTRA : 17.00 (-0.70%)
Natera Receives Unique Z-Code for Its Kidney Transplant Rejection Monitoring Test

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the assignment of a unique Z-code for the company's kidney transplant rejection assay, representing a key reimbursement...

NTRA : 17.00 (-0.70%)
PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects

PerkinElmer's (PKI) Vanadis NIPT is a more cost effective and non-invasive screening system compared to traditional ones.

NTRA : 17.00 (-0.70%)
ILMN : 328.90 (+1.81%)
VEEV : 90.41 (+0.41%)
PKI : 85.37 (+2.87%)
Natera Inc Down 34.8% Since SmarTrend Downtrend Call (NTRA)

SmarTrend identified a Downtrend for Natera Inc (NASDAQ:NTRA) on September 13th, 2018 at $24.86. In approximately 2 months, Natera Inc has returned 34.84% as of today's recent price of $16.20.

NTRA : 17.00 (-0.70%)
Look for Shares of Natera Inc to Potentially Rebound after Yesterday's 20.70% Sell Off

Natera Inc (NASDAQ:NTRA) traded in a range yesterday that spanned from a low of $13.70 to a high of $18.08. Yesterday, the shares fell 20.7%, which took the trading range below the 3-day low of $20.17...

NTRA : 17.00 (-0.70%)
Natera (NTRA) Reports Q3 Loss, Misses Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -6.52% and -2.38%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 17.00 (-0.70%)
Natera: 3Q Earnings Snapshot

SAN CARLOS, Calif. (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $29.6 million in its third quarter.

NTRA : 17.00 (-0.70%)
Will New Products Drive TransEnterix's (TRXC) Q3 Earnings?

Among the recent developments, in the third quarter, TransEnterixs (TRXC) gains an FDA approval for its additional 5 millimeter Senhance System instruments.

HUM : 306.07 (-0.41%)
NTRA : 17.00 (-0.70%)
HAE : 103.24 (-0.92%)
TRXC : 3.02 (-1.95%)
Natera Announces Third Quarter 2018 Earnings Conference Call

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its third quarter ended Sept. 30, 2018,...

NTRA : 17.00 (-0.70%)
Will CVS Health's (CVS) PBM Strength Boost Q3 Earnings?

Despite a challenging pricing scenario, CVS Health (CVS) is currently gaining on high level of service and execution as well as a competitive pricing along with unique integrated model.

HUM : 306.07 (-0.41%)
CVS : 73.41 (+0.10%)
NTRA : 17.00 (-0.70%)
HAE : 103.24 (-0.92%)
Will Obalon's (OBLN) Q3 Earnings Reflect Growth in U.S.?

Obalon (OBLN) is expected to register robust U.S. revenues in Q3, backed by higher reorders from existing accounts and new order bookings.

HUM : 306.07 (-0.41%)
NTRA : 17.00 (-0.70%)
OBLN : 1.85 (+4.52%)
HAE : 103.24 (-0.92%)
Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine

Combines Neon's Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic Non-Small Cell Lung Cancer Trial

NTRA : 17.00 (-0.70%)
NTGN : 5.61 (-1.41%)
Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and Neon Therapeutics, Inc. (NASDAQ: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today...

NTRA : 17.00 (-0.70%)
NTGN : 5.61 (-1.41%)
Report: Developing Opportunities within Natera, InnerWorkings, Chanticleer, NN, Stoneridge, and Avid Technology -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natera, Inc. (NASDAQ:NTRA),...

CCLRU : 13.5000 (+8.00%)
NTRA : 17.00 (-0.70%)
NNBR : 6.99 (+1.45%)
BURG : 2.08 (+14.92%)
INWK : 3.68 (-2.65%)
SRI : 24.68 (-0.36%)
AVID : 6.33 (+1.77%)
Natera Inc Set to Possibly Rebound After Yesterday's Selloff of 2.17%

Natera Inc (NASDAQ:NTRA) traded in a range yesterday that spanned from a low of $19.91 to a high of $20.83. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $20.05...

NTRA : 17.00 (-0.70%)
Natera: 1Q Earnings Snapshot

SAN CARLOS, Calif. (AP) _ Natera Inc. (NTRA) on Tuesday reported a loss of $32.9 million in its first quarter.

NTRA : 17.00 (-0.70%)
Natera Reports First Quarter 2018 Financial Results

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the first quarter ended March 31, 2018, and provided...

NTRA : 17.00 (-0.70%)
Natera Inc. Announces First Quarter 2018 Earnings Conference Call

Natera, (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its first quarter ended March 31, 2018,...

NTRA : 17.00 (-0.70%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA +1.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures closed the Tuesday session with most contracts fractionally to 1 3/4 cents higher, despite larger carryout estimates for both the US and World. USDA updated their monthly S&D table this morning showing no change to the production side fo...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar